Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

EQ

Equillium (EQ)

Equillium Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EQ
DateTimeSourceHeadlineSymbolCompany
12/13/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
12/12/20245:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
12/12/20245:43PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EQEquillium Inc
12/12/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
11/14/20249:50PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EQEquillium Inc
11/13/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
11/13/20244:01PMBusiness WireEquillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:EQEquillium Inc
11/13/20248:00AMBusiness WireEquillium to Present at the Stifel Healthcare ConferenceNASDAQ:EQEquillium Inc
11/12/20248:00AMBusiness WireEquillium Announces Poster Presentation at the Society for Immunotherapy of CancerNASDAQ:EQEquillium Inc
10/31/202412:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EQEquillium Inc
10/31/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
10/31/20247:00AMBusiness WireEquillium Maintains Rights to Itolizumab Following Ono PartnershipNASDAQ:EQEquillium Inc
10/30/20248:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
10/29/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
10/07/20248:00AMBusiness WireEquillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of CancerNASDAQ:EQEquillium Inc
09/17/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQEquillium Inc
09/10/20248:00AMBusiness WireEquillium to Present at the Stifel Virtual Inflammation & Immunology SummitNASDAQ:EQEquillium Inc
09/04/20248:00AMBusiness WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
08/28/20248:00AMBusiness WireEquillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor ConferenceNASDAQ:EQEquillium Inc
08/08/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQEquillium Inc
08/08/20244:01PMBusiness WireEquillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical HighlightsNASDAQ:EQEquillium Inc
08/06/20248:00AMBusiness WireEquillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host DiseaseNASDAQ:EQEquillium Inc
07/23/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
07/18/20242:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
07/18/20241:57PMBusiness WireEquillium Announces Second Quarter 2024 Estimated Cash and Investments BalanceNASDAQ:EQEquillium Inc
07/02/20248:00AMBusiness WireEquillium to Participate in Upcoming Investor ConferencesNASDAQ:EQEquillium Inc
06/12/20248:00AMBusiness WireEquillium to be included in the Russell Microcap® IndexNASDAQ:EQEquillium Inc
06/05/20248:00AMBusiness WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EQEquillium Inc
06/04/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
06/04/20248:00AMBusiness WireEquillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia AreataNASDAQ:EQEquillium Inc
 Showing the most relevant articles for your search:NASDAQ:EQ

Your Recent History

Delayed Upgrade Clock